Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
EDIT

Editas Medicine

$29.80

0.7 (2.41%)

16:05
08/16/18
08/16
16:05
08/16/18
16:05
Hot Stocks
Editas Medicine announces completion of recombinant DNA committee registration »

Editas Medicine announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

Over a week ago
EDIT

Editas Medicine

$29.00

1.36 (4.92%)

09:59
08/09/18
08/09
09:59
08/09/18
09:59
Conference/Events
Editas Medicine management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

EDIT

Editas Medicine

$29.06

0.38 (1.33%)

16:19
08/06/18
08/06
16:19
08/06/18
16:19
Earnings
Editas Medicine reports Q2 EPS (82c), consensus (67c) »

Reports Q2 revenue $7.4M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

AGN

Allergan

$184.90

-1.04 (-0.56%)

, EDIT

Editas Medicine

$29.05

0.37 (1.29%)

16:06
08/06/18
08/06
16:06
08/06/18
16:06
Hot Stocks
Allergan subsidiary to commercialize Editas Medicine's EDIT-101 »

Allergan (AGN) and Editas…

AGN

Allergan

$184.90

-1.04 (-0.56%)

EDIT

Editas Medicine

$29.05

0.37 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

LNEGY

Linde

$0.00

(0.00%)

, PX

Praxair

$164.22

1.065 (0.65%)

19:30
08/05/18
08/05
19:30
08/05/18
19:30
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

LNEGY

Linde

$0.00

(0.00%)

PX

Praxair

$164.22

1.065 (0.65%)

BRK.A

Berkshire Hathaway

$304,902.00

3752 (1.25%)

BRK.B

Berkshire Hathaway

$200.40

2.19 (1.10%)

AAPL

Apple

$208.00

0.65 (0.31%)

VIAB

Viacom

$29.09

0.5 (1.75%)

VIA

Viacom

$33.70

0.35 (1.05%)

SYF

Synchrony

$29.85

0.36 (1.22%)

CRSP

Crispr Therapeutics

$47.60

-1.17 (-2.40%)

EDIT

Editas Medicine

$28.68

-0.78 (-2.65%)

NTLA

Intellia Therapeutics

$26.07

-0.47 (-1.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

  • 08

    Aug

  • 09

    Aug

  • 09

    Aug

  • 14

    Aug

CRSP

Crispr Therapeutics

$47.60

-1.17 (-2.40%)

, EDIT

Editas Medicine

$28.68

-0.78 (-2.65%)

12:33
08/04/18
08/04
12:33
08/04/18
12:33
Periodicals
CRISPR technology still promising, Barron's says »

The gene-editing…

CRSP

Crispr Therapeutics

$47.60

-1.17 (-2.40%)

EDIT

Editas Medicine

$28.68

-0.78 (-2.65%)

NTLA

Intellia Therapeutics

$26.07

-0.47 (-1.77%)

RHHBY

Roche

$0.00

(0.00%)

TMO

Thermo Fisher

$233.31

0.13 (0.06%)

ILMN

Illumina

$332.41

-0.32 (-0.10%)

QGEN

Qiagen

$38.09

0.115 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

  • 08

    Aug

  • 08

    Aug

  • 14

    Aug

  • 21

    Aug

  • 27

    Aug

CRSP

Crispr Therapeutics

$51.07

-6.19 (-10.81%)

, EDIT

Editas Medicine

$32.55

-2.83 (-8.00%)

12:27
07/24/18
07/24
12:27
07/24/18
12:27
Hot Stocks
Crispr Therapeutics drops 11%, leads Crisper stocks lower »

Shares of Crispr…

CRSP

Crispr Therapeutics

$51.07

-6.19 (-10.81%)

EDIT

Editas Medicine

$32.55

-2.83 (-8.00%)

NTLA

Intellia Therapeutics

$28.32

-2.12 (-6.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
NTLA

Intellia Therapeutics

$31.35

1.98 (6.74%)

, EDIT

Editas Medicine

$36.46

1.31 (3.73%)

08:08
07/18/18
07/18
08:08
07/18/18
08:08
Recommendations
Intellia Therapeutics, Editas Medicine, Crispr Therapeutics analyst commentary at Jefferies »

Study in Nature Biotech…

NTLA

Intellia Therapeutics

$31.35

1.98 (6.74%)

EDIT

Editas Medicine

$36.46

1.31 (3.73%)

CRSP

Crispr Therapeutics

$61.98

1.95 (3.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EDIT

Editas Medicine

$36.20

-1.71 (-4.51%)

, NTLA

Intellia Therapeutics

$30.55

-2.05 (-6.29%)

13:23
07/16/18
07/16
13:23
07/16/18
13:23
Periodicals
Editas tells CNBC 'not specifically concerned about' Crisper study »

Editas Medicine (EDIT)…

EDIT

Editas Medicine

$36.20

-1.71 (-4.51%)

NTLA

Intellia Therapeutics

$30.55

-2.05 (-6.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRSP

Crispr Therapeutics

$61.24

-4.5 (-6.85%)

, EDIT

Editas Medicine

$36.06

-1.85 (-4.88%)

11:17
07/16/18
07/16
11:17
07/16/18
11:17
Hot Stocks
Crisper names fall after study finds 'large deletions' in DNA breaks »

Shares of Crispr…

CRSP

Crispr Therapeutics

$61.24

-4.5 (-6.85%)

EDIT

Editas Medicine

$36.06

-1.85 (-4.88%)

NTLA

Intellia Therapeutics

$30.53

-2.07 (-6.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.